Pharma channel feed

GE Health­Care hits the road in a health tech bus to bring its lat­est so­lu­tions to hos­pi­tal doorsteps

Last week
Marketing

GSK's Vi­iV Health­care takes Shut­ter­stock-part­nered cam­paign in new di­rec­tion

Last week
Marketing

Ex­clu­sive: As­traZeneca signs off on a ‘car­bon neg­a­tive’ new biotech build­ing for one of its lat­est buy­outs

Last week
Bioregnum

No­vo Nordisk’s US semaglu­tide man­u­fac­tur­ing site un­der the spot­light again as 2022 mon­i­tor­ing is­sue sur­faces

Last week
Manufacturing

Physi­cians see ‘new era for weight loss med­ica­tions’ with the ar­rival of No­vo, Lil­ly GLP-1 meds, sur­vey says

Last week
Marketing

Ac­tor Er­ic Ston­estreet talks about his re­al 'mod­ern fam­i­ly' in aware­ness cam­paign for eye dis­ease

Last week
Marketing

Mod­er­na de­creas­es mR­NA pro­duc­tion with Lon­za in Switzer­land, brings some man­u­fac­tur­ing in-house

Last week
Manufacturing

In­cyte ad­vances its Opzelu­ra eczema cam­paign with a ‘reimag­ine’ theme  

Last week
Marketing

Elon Musk's brain-com­put­er pro­gram be­gins re­cruit­ing paral­y­sis pa­tients

Last week
R&D
FDA+

FDA un­der­scores qual­i­ty, safe­ty con­cerns with Intar­cia’s di­a­betes treat­ment ahead of ad­comm

Last week
FDA+

It’s al­most the end of the road for Fresh Tracks as board sup­ports liq­ui­da­tion

Last week
People

Ther­mo Fish­er is ready to ex­pand its vi­ral vec­tor pro­duc­tion site in Mass­a­chu­setts once there’s ‘de­mand for it’

Last week
Manufacturing

Eli Lil­ly sues com­pounders and med­ical spas over sales of un­ap­proved copy­cats of its di­a­betes block­buster Moun­jaro

Last week
Law

House law­mak­ers press CMS on mon­i­tor­ing re­bate in­for­ma­tion, tout PBM re­forms at hear­ing

Last week
FDA+

Al­ler­gan on the hook for $160M for hy­dro­cor­ti­sone ‘abuse of dom­i­nance,’ UK court rules

Last week
Law

Heron Ther­a­peu­tics launch­es patent suit against My­lan over po­ten­tial gener­ic for chemo-re­lat­ed nau­sea

Last week
Law

Two phar­ma­cy ben­e­fit man­ag­er stud­ies find in­creas­ing fees and de­clin­ing opin­ions as House con­sid­ers ac­tion

Last week
Marketing

Mar­ket­ingRx roundup: Ab­bott teams with Weight­Watch­ers for glu­cose mon­i­tor­ing; Ha­le­on’s Advil starts ‘pain eq­ui­ty’ ef­fort

Last week
Marketing

Q&A: Gilead pub­lic af­fairs chief on new strat­e­gy, Tik­Tok, and why the com­pa­ny won’t ‘keep do­ing things the same way’ 

Last week
Marketing

Iver­ic, Astel­las eye US la­bel ex­pan­sion for ge­o­graph­ic at­ro­phy drug af­ter pos­i­tive two-year da­ta

Last week
R&D

Mer­ck’s women’s health spin­off Organon looks for phar­ma­ceu­ti­cals, di­ag­nos­tics, de­vices to fill out its pipeline

Last week
People

As­traZeneca rolls up car­dio­vas­cu­lar, re­nal and meta­bol­ic in­ter­con­nec­tions in film and dig­i­tal ef­fort

Last week
Marketing

AARP and non­prof­its ar­gue Medicare price ne­go­ti­a­tions are 'im­per­a­tive' to se­niors

Last week
Law

CDER di­rec­tor urges man­u­fac­tur­ers to work with FDA to fix in­spec­tion is­sues be­fore shut­ting down

Last week
FDA+
Manufacturing
First page Previous page 12345 Next page Last page
A service from the Financial Times